Polyrizon (PLRZ) Stock Price, News & Analysis

Company Overview

Polyrizon, Inc. (NASDAQ: PLRZ) is an advanced materials recovery company specializing in the development and commercialization of proprietary technologies for the recycling of polyolefin plastic waste. Leveraging a catalytic pyrolysis process, Polyrizon converts mixed post-consumer and industrial plastic feedstocks into hydrocarbon oils that can be further refined into virgin-grade polymer resins and chemical intermediates. The company’s integrated approach encompasses feedstock acquisition, process engineering, product purification and off-taker partnerships to deliver a circular solution to plastic pollution.

Headquartered in North America, Polyrizon operates across multiple jurisdictions through a hybrid model of wholly owned facilities and strategic joint ventures. The company’s pilot plant in the United States serves as the technical core, where engineering teams scale the catalytic reactor design and optimize operating conditions for diverse waste streams. In parallel, Polyrizon has established partnerships in Europe and Asia to assess local feedstock availability, regulatory frameworks and potential manufacturing alliances. This international footprint is designed to support the company’s goal of licensing its technology to regional partners and operators.

Polyrizon’s product portfolio includes pyrolysis oil grades tailored for steam-cracking units, specialty chemical applications and direct polymer re-extrusion. By delivering a high-purity hydrocarbon output, the company enables downstream producers to reduce reliance on virgin fossil feedstocks and achieve lower lifecycle greenhouse gas emissions. In addition to its core recycling platform, Polyrizon offers engineering design services, equipment supply and ongoing technical support to project developers, EPC firms and petrochemical producers seeking to incorporate chemical recycling into existing asset bases.

Founded in the early 2020s by a team of chemical engineers and sustainability entrepreneurs, Polyrizon is led by CEO Alexandra Ramirez, whose prior experience includes leadership roles in the petrochemical and cleantech sectors. The executive team is supported by a board of directors with backgrounds in industrial chemistry, waste management and capital markets. Driven by a commitment to environmental stewardship and resource efficiency, Polyrizon aims to advance plastic circularity at commercial scale and forge a new paradigm in sustainable materials management.

Key Stats

• Today's Range: $0.69 to $0.72
• 50-Day Range: $0.65 to $285.00
• 52-Week Range: $0.55 to $1,200.00
• Volume: 91,531 shs
• Average Volume: 323,196 shs
• Market Capitalization: $3.77 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PLRZ Stock Analysis - Frequently Asked Questions

How have PLRZ shares performed this year?

Polyrizon's stock was trading at $542.50 at the beginning of 2025. Since then, PLRZ shares have decreased by 99.9% and is now trading at $0.7070.

When did Polyrizon's stock split?

Polyrizon's stock reverse split before market open on Tuesday, May 27th 2025.A 1-250 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

When did Polyrizon IPO?

Polyrizon (PLRZ) raised $4 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 958,903 shares at $4.38 per share.

How do I buy shares of Polyrizon?

Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PLRZ
• Previous Symbol: NASDAQ:PLRZ
• CIK: 1893645
• Web: www.polyrizon-biotech.com
• Phone: 972-55-433-5665
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 10.16
• Quick Ratio: 10.16

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $315.05 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 5,330,000
• Free Float: N/A
• Market Cap: $3.77 million
• Optionable: N/A
• Beta: N/A